Relay Therapeutics is trading 4.1% down at $18.31 amid a mixed broader market backdrop and a lack of stock-specific catalysts.
- The move appears to be driven by normal market volatility and positioning rather than a reaction to a clear corporate event.
- There have been no new company announcements, earnings reports, or major analyst actions reported today.
- Major market indices remain only slightly changed, highlighting the stock's independent price action.